elaine s ullian  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in elaine s ullian independent lead director at hologic inc view full profile are you elaine s ullian claim your profile   sign up for equilar atlas and view elaine s ullians full profile with equilar atlas you can identify corporate executives in elaine s ullians network and community follow changes in elaine s ullians employment and moneyinmotion connect with elaine s ullian through your network of contacts elaine s ullians executive work history current independent lead director hologic inc past to view elaine s ullians complete executive work history sign up now education ba tufts university masters university of michigan age      elaine s ullians biography ms ullian served as president and chief executive officer of boston medical center a private notforprofit bed academic medical center with a communitybased focus from  through january  from  to  she served as president and chief executive officer of boston university medical center hospital from  to  ms ullian served as president and chief executive officer of faulkner hospital she also serves as a director of thermo fisher scientific inc and hologic inc ms ullian holds a ba in political science from tufts university and an mph from the university of michigan skills and qualifications  read more ms ullian served as president and chief executive officer of boston medical center a private notforprofit bed academic medical center with a communitybased focus from  through january  from  to  she served as president and chief executive officer of boston university medical center hospital from  to  ms ullian served as president and chief executive officer of faulkner hospital she also serves as a director of thermo fisher scientific inc and hologic inc ms ullian holds a ba in political science from tufts university and an mph from the university of michigan skills and qualifications ms ullian brings significant leadership experience acquired as the ceo of large health care providers to our board of directors the knowledge she obtained serving as an executive together with her extensive experience serving on the boards of directors of multiple public companies in the healthcare field provide her with the expertise required to serve as one of our colead independent directors and as the chair of our corporate governance and nominating committee she also provides the board with the perspective of providers payors and patients for whom our products are intended source vertex pharmaceuticals incorporated on    sign up for equilar atlas and view elaine s ullians full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like elaine s ullian more specifically youll be able to identify corporate executives in elaine s ullians network and community follow changes in elaine s ullians employment and moneyinmotion connect with elaine s ullian through your network of conections view full profile   search for over  executive profiles bio example elaine s ullian elaine s ullians connections  sign up now to view elaine s ullians  connections » ian f smith executive vice president chief operating officer and chief financial officer vertex pharmaceuticals incorporated glenn p muir former employee hologic inc jim p manzi board member thermo fisher scientific inc marijn e dekkers board member general electric company nelson j chai former chief financial officer merrill lynch robert a ingram board member cree inc peter mueller former employee vertex pharmaceuticals incorporated joshua s boger board member vertex pharmaceuticals incorporated c martin harris board member invacare corporation tyler jacks board member thermo fisher scientific inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla daniel a dematteo executive chairman gamestop corp david j oconnor president and ceo the madison square garden company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax  7   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied elaine ullian  vertex pharmaceuticals incorporated  zoominfocom﻿ hologic inc holx vp karleen marie oberton sells 7 shares  chaffey breeze daily ratings  news for hologic inc complete the form below to receive the latest headlines and analysts recommendationsfor hologic inc with our free daily email newsletter follow chaffeybreeze recent posts ncs multistage holdings inc ncsm stock rating reaffirmed by royal bank of canada nasdaq inc nasdaqndaq expected to post earnings of  per share j d wetherspoon plc jdw insider miles slade acquires  shares of stock first defiance financial corp nasdaqfdef upgraded to buy by sandler o’neill travelcenters of america llc ta downgraded to “sell” at zacks investment research corcept therapeutics incorporated cort upgraded by zacks investment research to strongbuy syros pharmaceuticals inc nasdaqsyrs downgraded by zacks investment research zacks evotec ag evtcy given consensus rating of “hold” by brokerages positive press coverage somewhat unlikely to affect kalvista pharmaceuticals kalv stock price strongbridge biopharma plc sbbp upgraded to “buy” by zacks investment research garmin ltd nasdaqgrmn stock rating upgraded by longbow research frequency electronics feim getting somewhat positive news coverage analysis shows soco international soclf upgraded to hold at zacks investment research amark precious metals inc amrk ceo gregory n roberts sells  shares of stock cohu inc cohu upgraded by bidaskclub to “buy” hsbc holdings plc hsba receives “outperform” rating from bnp paribas hologic inc holx vp karleen marie oberton sells 7 shares eurocell plc’s ecel buy rating reaffirmed at canaccord genuity mondi plc nasdaqmondy downgraded by zacks investment research to hold somewhat positive news coverage somewhat unlikely to impact kentucky first federal bancorp nasdaqkffb share price hologic inc holx vp karleen marie oberton sells 7 shares posted by lucas kauffman on jul th   no comments hologic inc nasdaqholx vp karleen marie oberton sold 7 shares of the business’s stock in a transaction that occurred on monday july 7th the stock was sold at an average price of  for a total transaction of  the sale was disclosed in a filing with the securities  exchange commission which is accessible through the sec website shares of hologic inc nasdaqholx traded up  on thursday reaching   shares of the company’s stock traded hands the firm has a market cap of 7 billion a pe ratio of  and a beta of  hologic inc has a month low of  and a month high of  the stock has a day moving average of  and a  day moving average of  get hologic inc alerts hologic nasdaqholx last released its earnings results on wednesday may th the medical equipment provider reported  earnings per share for the quarter topping the consensus estimate of  by  hologic had a return on equity of  and a net margin of  the business had revenue of 7 million during the quarter compared to the consensus estimate of  million during the same period last year the company earned 7 earnings per share the business’s revenue for the quarter was up  compared to the same quarter last year on average equities research analysts expect that hologic inc will post  earnings per share for the current year trademark violation notice “hologic inc holx vp karleen marie oberton sells 7 shares” was originally reported by chaffey breeze and is owned by of chaffey breeze if you are reading this story on another website it was illegally copied and republished in violation of us and international trademark  copyright legislation the correct version of this story can be read at httpswwwchaffeybreezecom7hologicincholxvpkarleenmarieobertonsells7shareshtml several hedge funds have recently added to or reduced their stakes in holx victory capital management inc increased its stake in hologic by  in the first quarter victory capital management inc now owns  shares of the medical equipment provider’s stock valued at 7 after buying an additional  shares during the period american century companies inc increased its stake in hologic by  in the first quarter american century companies inc now owns  shares of the medical equipment provider’s stock valued at  after buying an additional  shares during the period bank of montreal can increased its stake in hologic by  in the first quarter bank of montreal can now owns 7 shares of the medical equipment provider’s stock valued at  after buying an additional  shares during the period ubs asset management americas inc increased its stake in hologic by  in the fourth quarter ubs asset management americas inc now owns  shares of the medical equipment provider’s stock valued at  after buying an additional 7 shares during the period finally pictet asset management ltd increased its stake in hologic by  in the first quarter pictet asset management ltd now owns  shares of the medical equipment provider’s stock valued at  after buying an additional  shares during the period institutional investors and hedge funds own  of the company’s stock a number of equities research analysts have recently weighed in on the stock stifel nicolaus boosted their price objective on shares of hologic from  to  and gave the stock a “buy” rating in a report on thursday may th jefferies group llc restated a “buy” rating and issued a  price objective on shares of hologic in a report on wednesday june th canaccord genuity restated a “buy” rating and issued a  price objective on shares of hologic in a report on tuesday may th piper jaffray companies restated a “buy” rating and issued a  price objective on shares of hologic in a report on friday july th finally barclays plc restated an “overweight” rating and issued a  price objective up from  on shares of hologic in a report on monday one analyst has rated the stock with a sell rating four have assigned a hold rating and nine have given a buy rating to the stock hologic has an average rating of “buy” and an average target price of 7 about hologic hologic inc is a developer manufacturer and supplier of diagnostics products medical imaging systems and surgical products with an emphasis on women’s health the company operates through four segments diagnostics breast health gyn surgical and skeletal health the diagnostics products include aptima family of assays thinprep system the rapid fetal fibronectin test and procleix blood screening assays receive news  ratings for hologic inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for hologic inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website form  hologic inc for jul  filed by ullian elaine research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  hologic inc for jul  filed by ullian elaine by k wizard—  pm et 7 httparchivefastedgarcomaczkcsmlssmzjtjpmx filed on july   more holx news hologic to announce financial results for the third quarter of fiscal  on wednesday august   pr newswire   pm et 7 briefhologic says holders of   convertible exchange senior notes due  are eligible to convert reuters   pm et 7 hologic delivers notice that holders of  convertible exchange senior notes due  are eligible to convert pr newswire   pm et 7 copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of 7 methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et 7 earnings  dividends  splits  upgrades 7 downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  holx stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsholx hologic inc    as of pm et 7 quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all hologic to announce financial results for the third quarter of fiscal  on wednesday august   pr newswire –  pm et 7 marlborough mass interested participants may listen to the call by dialing 77 or 7 and referencing access code  hologic holx will provide a live webcast of the call on the companys website at httpinvestorshologiccom and the call will be archived there for  days briefhologic says holders of   convertible exchange senior notes due  are eligible to convert reuters –  pm et 7 hologic inc holx  hologic holx delivers notice that holders of  convertible exchange senior notes due  are eligible to convert  hologic inc holx  conversion right triggered because closing price of cos stock exceeded about  which is  of conversion price for notes hologic delivers notice that holders of  convertible exchange senior notes due  are eligible to convert pr newswire –  pm et 7 marlborough mass the conversion right has been triggered because the closing price of the companys common stock exceeded approximately  which is  of the conversion price for the notes for at least  of the  consecutive trading days ending on june   briefhologic obtains ce mark in europe for panther fusion system reuters –  am et  hologic inc holx  obtained a ce mark in europe for its new panther fusion system and panther fusion assays for flu and respiratory testing source text for eikon further company coverage hologics new panther fusion® system flu and respiratory assays now ce marked in europe pr newswire –  am et  marlborough mass the panther fusion module is an inlab upgrade to the panther® instrument additional benefits include a higher throughput of up to  panther fusion tests in eight hours or up to  fusion and aptima® tests briefhologic announces fda clearance of aptima assay to detect herpes simplex virus    reuters –  am et  hologic inc holx  hologic holx announces fda clearance of aptima® assay to detect herpes simplex virus     hologic inc holx says test will be commercially available in  united states us territories and puerto rico source text for eikon further company coverage hologic announces fda clearance of aptima® assay to detect herpes simplex virus    pr newswire –  am et  marlborough mass the aptima hsv    assay can be used to qualitatively detect and differentiate between hsv and hsv helping our clinical lab customers consolidate testing on the panther system enables them to be more efficient and productive said tom west president of the diagnostic solutions division at hologic technical reports on medical equipment equities  hologic wright medical globus medical and edwards lifesciences pr newswire –  am et  new york june   dailystocktrackercom has issued research reports on hologic inc holx wright medical group nv wmgi globus medical inc gmed and edwards lifesciences corp ew medical appliances and equipment companies engage in the manufacture of medical instruments such as dental and surgical appliances httpdailystocktrackercomregister hologic  marlborough massachusetts headquartered hol briefhologic receives expanded fda clearance to market cynosures sculpsure reuters –  am et  hologic inc holx  hologic holx receives expanded fda  clearance to market cynosures sculpsure® for noninvasive body contouring of back inner and outer thighs source text for eikon further company coverage hologic receives expanded fda k clearance to market cynosures sculpsure® for noninvasive body contouring lipolysis of back inner and outer thighs pr newswire –  am et  marlborough mass sculpsure is a clinically proven nonsurgical body contouring treatment designed to permanently eliminate fat cells in problem areas briefhologic inc updates on fdas approval of genius d mammography exam reuters –  am et 7 hologic inc holx  fda approves hologics genius d mammography exam as the only mammogram superior for women with dense breasts source text for eikon further company coverage fda approves hologics genius™ d mammography™ exam as the only mammogram superior for women with dense breasts pr newswire –  am et 7 marlborough mass the genius exam has been commercially available in the united states since  and the newly approved physician labeling is based on clinical studies proving that the exam improves invasive breast cancer detection while reducing unnecessary recalls among women of all breast densities including those with dense breasts charles j dockendorff elected to hologic board of directors pr newswire –  pm et  marlborough mass mr dockendorff who has more than  years of experience in the global healthcare industry was formerly the executive vice president and chief financial officer of covidien a public medical device and supplies company acquired by medtronic in  briefhologic announces q revenue 7 million reuters –  pm et  hologic inc holx  hologic holx announces financial results for second quarter of fiscal   q gaap earnings per share   q earnings per share view   thomson reuters ibes  q revenue 7 million versus ibes view  million  q nongaap earnings per share   sees  gaap revenue  to  million hologic announces financial results for second quarter of fiscal  pr newswire –  pm et  marlborough mass hologic holx posted good financial results in the second quarter with both revenues and eps exceeding our guidance said steve macmillan hologics chairman president and chief executive officer key financial results for the fiscal second quarter are shown in the table below hologic to webcast presentations at upcoming investor conferences pr newswire –  pm et  marlborough mass each presentation will be webcast live and may be accessed through a link on the investors section of hologics holx website at httpinvestorshologiccom the webcasts will be available for  days following the events research reports initiation on medical equipment stocks  edwards lifesciences hologic and stryker pr newswire –  am et  new york may   stockcallerscom takes a closer look at these medical appliances and equipment stocks for today edwards lifesciences corp ew hologic inc holx and stryker corp syk these companies operate in the healthcare sector which has received an outperform rating from charles schwab on april th  due to solid balance sheets attractive dividend yields an improved overall cost st page page  todays and upcoming events aug  holx to announce q earnings after market confirmed aug  holx earnings conference call at  pm listen past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe elaine ullian  hologic inc  email executive officer  hologiccom  phone 77   business card for elaine ullian elaine ullian executive officer bedford ma areaemail avail  day free trial hologic inc  campus dr marlborough ma 7 tel 7 7 wwwhologiccom last updated on    get contact info  its free and takes  seconds opt out or update this contact opt out update name update title update phone update email not at this company anymore about elaine ullian elaine ullian works as an executive officer for hologic inc at bedford ma the companys webpage is httpwwwhologiccom for email phone number and executive profiles for executive officer and other executives of hologic inc at bedford ma check hologic inc at joesdatacom not the elaine ullian you are looking for do a quick search in our website and find other people named elaine ullian elaine ullians work history no information available elaine ullians education no information available elaine ullians coworkers as of july   elaine ullian has  coworkers under the company name hologic inc at joesdatacom about hologic inc hologic inc is a developer manufacturer and supplier of diagnostics products medical imaging systems and surgical products to serving the healthcare needs of women the company operates in four segments breast health diagnostics gyn surgical and skeletal health the company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives on august   the company acquired genprobe incorporated genprobe genprobe is engaged in molecular diagnostics products and services which are used to diagnose human diseases screen donated human blood and test transplant compatibility source sec reports company news  7hologic applauds cigna as first national insurer to cover breast tomosynthesis for routine breast cancer screening people in the same industry raymond huggenbergerchief executive officerinogenmorgan nieldschief executive officerfischer medical technologies incwendy demonicoprincipalfluidnet corporationglen prasserchief executive officerbeacon orthopaedicsjoe wolfcalechief executive officerfwradiologyhoward rowepartnercleancut technologies llc about us privacy terms of use work for us contact us people directory a b c d e f g h i j k l m n o p q r s t u v w x y z company directory a b c d e f g h i j k l m n o p q r s t u v w x y z copyright   joesdatacom all rights reserved elaine ullian board dir valeant pharmaceuticals international a publisher of business information since         search business search executive   advanced search   sign in    hints profile of elaine ullian   elaine ullian   board dir  valeant pharmaceuticals international   elaine ullian email  please login   company name  valeant pharmaceuticals international   company website  wwwvaleantcom   company address  one enterprise aliso viejo caunited states   elaine ullian profile  board dir  valeant pharmaceuticals international   elaine ullian biography  elaine ullian is president and chief executive officer of boston medical center a private notforprofit bed academic medical center with a communitybased focus established in july  boston medical center the countrys first full asset merger of two public hospitals with a private academic medical center is the merged entity of boston city hospital boston specialty rehabilitation hospital and boston university medical center hospital boston medical center has nearly  employees  physicians and an annual operating budget of  billionboston medical center offers a full spectrum of pediatric and adult care services from advanced specialty services to outreach programs for the citys homeless population and frail elderly in partnership with fifteen community health centers and its boston healthnet health plan a medicaid expansion hmo boston medical center is committed to providing exceptional care without exception with particular focus on vulnerable populations boston medical center is a major teaching affiliate of boston university school of medicine public health and dental medicinemrs ullian had previously served as president and chief executive officer of boston university medical center hospital she was recruited to this position jointly by the board of the medical center hospital and by mayor thomas menino in order to lead the merger that ultimately created boston medical center in  prior to her role at boston university medical center hospital she served as president and chief executive officer of faulkner hospital prior to faulkner hospital she held leadership positions at new england medical center hospital and with the massachusetts department of public healthmrs ullian is active in many professional and service organizations she is one of seven members of the boston public health commission and serves on the board of the massachusetts hospital association she is the former chairperson of the conference of boston teaching hospitals she also serves on the boards of vertex pharmaceuticals thermo electron the boston globe and citizens bank of massachusetts mrs ullian served on the transition teams for former governors paul cellucci and william weld and for mayor thomas m meninomrs ullian is an associate professor of boston university school of public health and a member of the faculty at the harvard university school of public health she holds a bachelor of arts degree from tufts university and a masters degree from the university of michiganmrs ullian is the recipient of numerous honors and awards in may  she was honored by the mattapan community health center for her leadership in public health in january  she was the recipient of the greater boston chamber of commerce pinnacle award for lifetime achievement in  she received the ywca womens achievement award and also the boston university school of medicine award of achievement in administration her other awards include the distinguished service award from tufts university the leadership award to women in business granted by the new england council the boston club achievement award the mass health council award for outstanding leadership in public health the abigail adams award presented by theassachusetts womens political caucus and the maimonides award for outstanding leadership in healthcare presented by the antidefamation league   elaine ullian colleagues  name title email geoffrey glass sr vp cio please login theo melaskyriazi board dir please login bary bailey exec vp please login wesley wheeler pres  north america global product development please login lawrence kugelman board dir please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved hologic  board of directors login register need help email us contact us products training support istore about careers media  investors  contact overview news webcasts and presentations financial and stock information all sec filings analyst coverage leadership team corporate governance board of directors board committees  proxy statement articles of incorporation and bylaws committee charters code of conduct product components compliance sunshine act compliance sustainability cynosure archive information faqs contact investor relations investor alerts interactive analyst center quick linkscorporate presentation corporate brochure  proxy statement  annual report on form k form q period ended april   email alerts contact ir elaine s ullian lead independent director former ceo and president boston medical center elaine s ullian has been a member of our board since october 7 and our lead independent director since june  ms ullian served as president and chief executive officer of boston medical center the successor of boston university medical center hospital from  until her retirement in january  in april  ms ullian was appointed president and chief executive officer of boston university medical center hospital from january  to march  ms ullian held the position of president and chief executive officer of faulkner corporationfaulkner hospital she holds two academic appointments associate professor at boston university school of medicine and lecturer at harvard university school of public health ms ullian also serves as a director of vertex pharmaceuticals incorporated where she is colead director chair of the corporate governance and nominating committee and a member of the management development and compensation committee and thermo fisher scientific inc where she is a member of the compensation committee ms ullian previously served as one of our directors from  to  and previously served as a director of valeant pharmaceuticals international inc member compensation committee chair nominating and corporate governance committee press investors events news resources  weee   events   news   locationsprivacy  terms  conditions  patent info  help  copyright  hologic incall rights reserved